Impact of Direct Acting Antiviral Therapy for Treatment of Hepatitis C Genotypes 1, 3 and 4: A Real Life Experience from India

OBJECTIVE: To assess impact of Direct Acting Antiviral (DAA) therapies for treatment of Hepatitis C Virus (HCV) genotypes 1, 3 and 4 in a real-world cohort from India. METHODS: Adults with chronic HCV infection treated with Sofosbuvir (SOF) and Ledipasvir (LDV) (genotypes 1 and 4) or SOF and Daclata...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Exp Hepatol
Main Authors: Mehta, Varun, Mahajan, Ramit, Midha, Vandana, Narang, Vikram, Kaur, Kirandeep, Singh, Arshdeep, Malhotra, Anand, Parvez, Aslam, Sood, Ajit
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5938329/
https://ncbi.nlm.nih.gov/pubmed/29743791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2017.06.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados